Literature DB >> 15142521

Pathogenic roles of B cells in human autoimmunity; insights from the clinic.

Flavius Martin1, Andrew C Chan.   

Abstract

The pathogenic roles of B cells in human autoimmune diseases involve a multitude of mechanistic pathways and include the well-established contributions of autoantibodies and immune complexes that induce local inflammatory reactions and tissue destruction. Recent results using several novel B cell-directed therapies have provided new insights into additional roles of B cells in human autoimmunity. In this review, we will highlight some of these studies and discuss how clinical insights parallel murine models of normal immunity and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142521     DOI: 10.1016/s1074-7613(04)00112-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

1.  A novel approach to paraneoplastic intestinal pseudo-obstruction.

Authors:  Ambuga Badari; Deborah Farolino; Eiad Nasser; Shahid Mehboob; David Crossland
Journal:  Support Care Cancer       Date:  2011-11-10       Impact factor: 3.603

2.  [Regulatory B cells and their role in maintaining peripheral tolerance].

Authors:  T Tretter; H-M Lorenz
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

3.  Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

Authors:  Kai W Bekar; Teresa Owen; Robert Dunn; Travis Ichikawa; Wensheng Wang; Roger Wang; Jennifer Barnard; Sean Brady; Sarah Nevarez; Bruce I Goldman; Marilyn Kehry; Jennifer H Anolik
Journal:  Arthritis Rheum       Date:  2010-08

4.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

Review 5.  New indications for biological therapies.

Authors:  Mariagrazia Catanoso; Nicolò Pipitone; Luca Magnani; Luigi Boiardi; Carlo Salvarani
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

6.  Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.

Authors:  Norihito Yazawa; Yasuhito Hamaguchi; Jonathan C Poe; Thomas F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

Review 7.  [Autoantibodies and antibody-secreting cells].

Authors:  F Hiepe; T Dörner
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

8.  MOP3, a component of the molecular clock, regulates the development of B cells.

Authors:  Yimin Sun; Zhihui Yang; Zeqing Niu; Jianxiao Peng; Qinghuan Li; Wanfen Xiong; Alan N Langnas; Mark Y Ma; Yong Zhao
Journal:  Immunology       Date:  2006-08-22       Impact factor: 7.397

9.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

10.  Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis.

Authors:  Paola Margutti; Paola Matarrese; Fabrizio Conti; Tania Colasanti; Federica Delunardo; Antonella Capozzi; Tina Garofalo; Elisabetta Profumo; Rachele Riganò; Alessandra Siracusano; Cristiano Alessandri; Bruno Salvati; Guido Valesini; Walter Malorni; Maurizio Sorice; Elena Ortona
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.